User talk:Noxoug1: Difference between revisions

This is my talk page – you can dialog with me hereNoxoug1 (talk) 15:41, 26 February 2019 (UTC)[reply]

Hello, Noxoug1. Just a note to say thanks for your contributions, and also that if you ever want to chat with folks who are also interested in Wikipedia’s health content, you should feel free to join the discussions at Wikipedia talk:WikiProject Pharmacology and Wikipedia talk:WikiProject Medicine. Please consider bookmarking those pages or putting them on your Help:Watchlist, and check in periodically to see if you can answer to other people’s questions, or want to post something yourself. WhatamIdoing (talk) 20:56, 4 August 2024 (UTC)[reply]

@WhatamIdoing I appreciate the note and shall check the pages. Noxoug1 (talk) 23:39, 11 August 2024 (UTC)[reply]

An automated process has detected that when you recently edited Axel Springer SE, you added a link pointing to the disambiguation page Axios.

(Opt-out instructions.) —DPL bot (talk) 19:54, 19 September 2024 (UTC)[reply]

An automated process has detected that when you recently edited Puma (brand), you added a link pointing to the disambiguation page Black Rock.

(Opt-out instructions.) —DPL bot (talk) 19:56, 30 October 2024 (UTC)[reply]

Welcome, welcome, welcome Noxoug1! I’m glad that you are joining the November 2024 drive! Please, have a cup of WikiTea, and go cite some articles.

Cielquiparle (talk) 09:53, 6 November 2024 (UTC)[reply]

The article Level Access has been proposed for deletion because of the following concern:

Fails to establish notability under WP:NCORP.

While all constructive contributions to Wikipedia are appreciated, pages may be deleted for any of several reasons.

You may prevent the proposed deletion by removing the {{proposed deletion/dated}} notice, but please explain why in your edit summary or on the article’s talk page.

Please consider improving the page to address the issues raised. Removing {{proposed deletion/dated}} will stop the proposed deletion process, but other deletion processes exist. In particular, the speedy deletion process can result in deletion without discussion, and articles for deletion allows discussion to reach consensus for deletion. Brandon (talk) 03:41, 8 January 2025 (UTC)[reply]

@Brandon thanks for flagging, i will look at improving the article. Noxoug1 (talk) 11:36, 8 January 2025 (UTC)[reply]

Hi Noxoug1. Thank you for your work on Nipocalimab. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:

Thanks for creating a page on this monoclonal antibody that’s in the clinical use; well-warranted. It’s appropriately referenced and structured.

To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Klbrain (talk) 15:07, 5 March 2025 (UTC)[reply]

Hello, I’m DMacks. I noticed that you added or changed content in an article, Physics Wallah, but you didn’t provide a reliable source. It’s been removed and archived in the page history for now, but if you’d like to include a citation and re-add it, please do so. You can have a look at referencing for beginners. If you think I made a mistake, you can leave me a message on my talk page. Thank you. DMacks (talk) 06:54, 19 March 2025 (UTC)[reply]

I was literally adding a citation when you reverted the edit 🙂 @DMacks Noxoug1 (talk) 06:57, 19 March 2025 (UTC)[reply]

D’oh! Carry on then…I’ll keep my fingers off that article for a while. DMacks (talk) 06:59, 19 March 2025 (UTC)[reply]

Looks fine, thanks for adding it. Due to the history of disruption at that article, my ‘undo’ trigger on it is pretty sensitive. DMacks (talk) 13:46, 19 March 2025 (UTC)[reply]

Hi Noxoug1. Thank you for your work on Anthony Hamilton (racing manager). Another editor, Noleander, has reviewed it as part of new pages patrol and left the following comment:

Notable subject. But it has no Categories, and also is nearly an orphan. Suggest find related articles and add links to this article.

To reply, leave a comment here and begin it with {{Re|Noleander}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Noleander (talk) 16:29, 16 May 2025 (UTC)[reply]

@Noleander: It is still in progress, thanks for the feedback, i will be adding cats with hotcat shortly Noxoug1 (talk) 16:33, 16 May 2025 (UTC)[reply]

Hi Noxoug1. Thank you for your work on Arsenate sulfate. Another editor, ARandomName123, has reviewed it as part of new pages patrol and left the following comment:

Please note that all the sources, except for Britannica, do not link to the correct article.

To reply, leave a comment here and begin it with {{Re|ARandomName123}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

ARandomName123 (talk)^{Ping me!} 16:34, 22 May 2025 (UTC)[reply]

An automated process has detected that when you recently edited Pelabresib, you added links pointing to the disambiguation pages MPL and CALR.

(Opt-out instructions.) —DPL bot (talk) 19:56, 22 May 2025 (UTC)[reply]

Hello Noxoug1. I am the declared connected contributor for Cohere. I noticed your previous edits to the article and would be grateful for the opportunity to work together to add additional content. Specifically, on the awards I am looking to include as per my suggestion on the Talk page. Editors have given me the greenlight in the past to make edits directly. If you agree with my suggestion, I am happy to take the time to implement. Thank you for your time and review, LivingInaCloud (talk) 11:54, 11 June 2025 (UTC)[reply]

Hello. You’re invited to participate in The World Destubathon. We’re aiming to destub a lot of articles and also improve longer stale articles. It started today on Monday June 16 and will run until Sunday July 13. There is over $3300 going into it, with $500 the top prize. If you are interested in winning something to save you money in buying books for future content, or just see it as a good editathon opportunity to see a lot of articles improved for subjects which interest you, sign up on the page in the participants section if interested. Even if you can only manage a few articles they would be very much appreciated and help make the content produced as diverse and broad as possible! ♦ Dr. Blofeld 09:50, 16 June 2025 (UTC)[reply]

@Dr. Blofeld i will sign-up, thanks for letting me know. Noxoug1 (talk) 16:17, 16 June 2025 (UTC)[reply]

Hello. I have some concerns about your recent edits. I saw you expanded 1996 Ugandan presidential election, which of course is welcome, but I noticed you added several references that did not support the information being added. For example you used this source to claim that Awori and Bwengye were not on the ballot and there were organisational challenges in the no party system, but the source says nothing of the sort (it actually says both are still candidates). There were several other issues with the expansion (such as introducing contradictory numbers), but as we all make mistakes, I didn’t see there was any point in raising it.

However, today I noticed that you had also expanded 1996 Ugandan parliamentary election, and referenced the constituency structure to the Nohlen et al book. I checked the book and it does not support the information you added (it states there were 39 women representatives, not 56, and that there were three from trade unions, which were not mentioned). You also introduce the claim that the election ” introduced several innovations in Uganda’s electoral system”, that “Campaign activities had to focus on individual merit rather than party platforms” and that “Buganda [had] the largest number of registered voters” and there was a “generally peaceful electoral process”, but none of these claims are supported by the Nohlen source (there is no subnational breakdown of registered voters). Where are you getting this information from and why are you sourcing it to a book that does not support the claims?

@Dr. Blofeld: You might like to be aware of this, seeing as you are reviewing these submissions for the destubathon challenge. Number 57 13:34, 23 June 2025 (UTC)[reply]

Thanks for spotting this Number 57. I just left a comment in reviewing that Nox’s sourcing on these election articles was a way off what was required too with lots of unsourced paragraphs and not of the expected quality. ♦ Dr. Blofeld 13:44, 23 June 2025 (UTC)[reply]

Your edit to Uganda Refinery Holding Company has been removed in whole or in part, as it appears to have added copyrighted material to Wikipedia without evidence of permission from the copyright holder. If you are the copyright holder, please read Wikipedia:Donating copyrighted materials for information on how to contribute your work appropriately. For legal reasons, Wikipedia strictly cannot host copyrighted text or images from print media or digital platforms without an appropriate and verifiable license. Contributions infringing on copyright will be removed. You may use external websites or publications as a source of information, but not as a source of content, such as sentences or images—you must write using your own words. Wikipedia takes copyright very seriously, and persistent violators of our copyright policy will be blocked from editing. See Wikipedia:Copying text from other sources for more information. This is your final warning. Further violation of Wikipedia’s copyright policy will result in you being blocked from editing. — Diannaa 🍁 (talk) 23:13, 26 June 2025 (UTC)[reply]

Thanks Diannaa. Yes be very careful to avoid copyright and paraphrasing Nox, it’s in the rules that if you repeatedly do it you can be disqualified.♦ Dr. Blofeld 07:05, 27 June 2025 (UTC)[reply]

Thanks for contributing to the article PS Lugard II. However, one of Wikipedia’s core policies is that material must be verifiable and attributed to reliable sources. You have recently used citations which copied, or mirrored, material from Wikipedia. This leads to a circular reference and is not acceptable. Most mirrors are clearly labeled as such, but some are in violation of our license and do not provide the correct attribution. Please help by adding alternate sources to the article you edited! If you need any help or clarification, you can look at Help:Contents/Editing Wikipedia or ask at Wikipedia:New contributors’ help page, or just ask me. Thank you. Sam Kuru (talk) 12:04, 27 June 2025 (UTC)[reply]

Thanks I’ll look and update it Noxoug1 (talk) 12:37, 27 June 2025 (UTC)[reply]

Just a reminder that pages in your personal sandbox are not allowed to be filed in mainspace categories alongside finished articles, per WP:USERNOCAT. Pages in your sandbox must stay out of any categories while they’re in sandbox, and may have categories added to them only after they’ve been moved into articlespace — adding it to categories while it’s still in your userspace is not making it an article, it’s making it a user sandbox page that can’t be in categories. Please don’t readd pages in your sandbox to categories, because they’re not allowed to be in categories. Bearcat (talk) 01:10, 13 July 2025 (UTC)[reply]

got it thanks, I’ll make the changes and remove the categories Noxoug1 (talk) 06:19, 13 July 2025 (UTC)[reply]

Hi, just a courtesy message to notify you in case you haven’t seen the Wikipedia:The World Destubathon contest update in the last few days that we’ve decided to run the full month until the 16th of July. For those who have been too busy to contribute, we would love some help in reaching 4000 articles by Wednesday night! At present we’re about 480 articles short!♦ Dr. Blofeld 16:48, 13 July 2025 (UTC)[reply]

Hello Noxoug1. We’ve been in touch before about Cohere and I am so grateful for your help with that.
I recently put together a draft for Nick Frosst, a Cohere co-founder, and would welcome the opportunity to collaborate with you on moving this to main space Wikipedia. You can see my initial draft here: https://en.wikipedia.org/wiki/User:LivingInaCloud/Nick_Frosst_DRAFT.
What do you think? LivingInaCloud (talk) 14:05, 21 July 2025 (UTC)[reply]

I do not see the draft page but let me know if the link is changed @LivingInaCloud Noxoug1 (talk) 11:09, 22 July 2025 (UTC)[reply]

Thanks Noxoug1 for responding. Sorry about the confusion. My initial draft is in my userspace.

What do you think? Thanks again, LivingInaCloud (talk) 12:01, 22 July 2025 (UTC)[reply]

Noxoug1, have you had a chance to look at the draft in my userspace? Looking forward to collaborating with you on this. LivingInaCloud (talk) 08:57, 27 July 2025 (UTC)[reply]

Hi Noxoug1. Thank you for your work on 225Ac-PSMA-R2. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:

Thanks for building this page for an an investigational radiopharmaceutical, notable given its coverage in published peer-review literature, and for entering clinical trials. It would now be helpful to link it from other articles.

To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Klbrain (talk) 22:33, 15 August 2025 (UTC)[reply]

Thanks @Klbrain I will look into it. Noxoug1 (talk) 08:18, 10 September 2025 (UTC)[reply]

Hi Noxoug1, I just wanted to let you know that I have added the new page reviewer user right to your account. This means you now have access to the page curation tools and can start patrolling pages from the new pages feed. If you asked for this at requests for permissions, please check back there to see if your access is time-limited or if there are other comments.

This is a good time to re-acquaint yourself with the guidance at Wikipedia:New pages patrol. Before you get started, please take the time to:

You can find a list of other useful links and tools for patrollers at Wikipedia:New pages patrol/Resources. If you are ever unsure what to do, ask your fellow patrollers or just leave the page for someone else to review – you’re not alone! _signed, Rosguill ^talk 18:35, 28 August 2025 (UTC)[reply]

Hi Noxoug1. Thank you for your work on Sefaxersen. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:

Thanks for creating this article on an investigational antisense oligonucleotide, which is far enough through clinical trials to have received significant coverage. One thing I spotted: try to be more specific with Categories. For example, rather than ‘Eye diseases’ (which this is not), use ‘Ophthalmology drugs’ (and similarly elsewhere).

To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Klbrain (talk) 09:25, 6 September 2025 (UTC)[reply]

Thanks @Klbrain Noted for the future. Noxoug1 (talk) 08:19, 10 September 2025 (UTC)[reply]

Hello, Noxoug1,

Thank you for creating Dazukibart.

I have tagged the page as having some issues to fix, as a part of our page curation process and note that:

Orphan: Please link other related, appropriate articles back to this article.

The tags can be removed by you or another editor once the issues they mention are addressed. If you have questions, leave a comment here and begin it with {{Re|Kudpung}}. Remember to sign your reply with ~~~~. For broader editing help, please visit the Teahouse.

Delivered via the Page Curation tool, on behalf of the reviewer.

Kudpung กุดผึ้ง (talk) 06:13, 7 September 2025 (UTC)[reply]

Hi Noxoug1. Thank you for your work on Votoplam. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:

What an interesting drug! A very interesting mechanism of action, with therapeutic potential for a disease with no current treatments that slow progression. Well-warranted and well-written. As another reviewer notes, it would be helpful to link this article from other pages so that others can benefit from the content.

To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)

Klbrain (talk) 21:01, 7 September 2025 (UTC)[reply]

Thanks @Klbrain I will look into it shortly. Noxoug1 (talk) 08:19, 10 September 2025 (UTC)[reply]

Good day, Chief! I salute thee. I recently saw one of your unusual marks on one of my articles. I was quite shocked when I received a mail concerning this particular article, of which you had marked; or perhaps, in your description, you described the character in the article as not notable enough. I can’t argue with you; you’ve been here before me, and you know almost everything. I believe you’ve marked my article because of whatever you believe to be right, based on the scheme of things or knowledge you’ve gained. But I can only appeal that you remove it, not because of anything. When you talked about Afenifere, the man will be mentioned! Even the President of the Federal Republic of Nigeria will described him as notable. This character, in my research, I discovered, had received one of Nigeria’s highest honors; can’t we still say the same man is not notable enough? The man is a writer; as a reference, different governors were seen attending his book launch. A keyword and search on Google will provide that vista. Aside from that, he’s the brother of some notable figure, a principal, a chief, chairman of some sort of writers’ association, which is recognized both at home and overseas. I’m defending this article not because i might be rebellious or full ignorance but because I’ve written something, and at this stage, it’s being marked as not notable enough. I fear for its future; it’s saddening enough. Please, I await your reply, Chief! Regards, 9aija. 9aija (talk) 20:29, 14 September 2025 (UTC)[reply]

The article Seinde Arogbofa 9aija (talk) 20:31, 14 September 2025 (UTC)[reply]

Hi again, Noxoug1. There are some personnel updates that I am looking to include in the Cohere article. I know you’re busy; I’m happy to put these in place with your approval. Thank you, LivingInaCloud (talk) 09:36, 17 September 2025 (UTC)[reply]

The page Clay Magouyrk has been speedily deleted from Wikipedia. This was done under section R2 of the criteria for speedy deletion, because it was a redirect from the article namespace to a different namespace except the Category, Template, Wikipedia, Help, or Portal namespaces.

Please do not recreate the material without addressing these concerns, but do not hesitate to add information in line with Wikipedia’s policies and guidelines. If you think this page should not have been deleted for this reason, you may contact the deleting administrator, or if you have already done so, you may open a discussion at Wikipedia:Deletion review. Liz ^{Read! Talk!} 17:55, 23 September 2025 (UTC)[reply]

Hi, this is an automated reminder as part of Global reminder bot to let you know that your permission “patroller” (New page reviewers) will expire on 00:00, 30 September 2025 (UTC). For most rights, you will need to renew at WP:PERM, unless you have been told otherwise when your right was approved. To opt out of user right expiry notifications, add yourself to m:Global reminder bot/Exclusion. Leaderbot (talk) 19:43, 23 September 2025 (UTC)[reply]